Categories: ArticlesInfoGraphics

Execs’ Views on Future Healthcare


View Comments

  • Metrics that do not take into consideration patient's views are at best irrelevant, at worst pernicious. The interests of the C-Suite, corporations and others in the command structure are not the same as patient's interests, despite all claims to the contrary.

Published by
Tags: Affordable Care ActBusiness of MedicineHealthcare PolicyHospital Medicine

Recent Posts

  • Reuters

Jazz Pharma’s sleep disorder treatment gets FDA nod

By Aakash B (Reuters) - The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's treatment for patients with a…

2 hours ago
  • Reuters

Congo Ebola outbreak spreads to city of Bunia

GOMA, Democratic Republic of Congo (Reuters) - Health authorities in Democratic Republic of Congo have confirmed a case of Ebola…

3 hours ago
  • Reuters

Jury finding upends Bayer’s Roundup defense strategy: experts

By Tina Bellon NEW YORK (Reuters) - Bayer AG had hoped a new trial strategy focusing jurors on scientific evidence…

4 hours ago
  • Reuters

With ADHD, amphetamine has double the psychosis risk of methylphenidate

By Gene Emery (Reuters Health) - Children and young adults with attention deficit-hyperactivity disorder (ADHD) who are treated with the…

5 hours ago
  • Reuters

U.S. jury hears more evidence as second phase of Roundup cancer trial begins

By Jim Christie SAN FRANCISCO (Reuters) - A lawyer for a man who sued Bayer AG unit Monsanto after developing…

5 hours ago
  • Reuters

FDA allows sale of certain blood pressure drugs amid shortage

(Reuters) - The U.S. Food and Drug Administration on Wednesday said it will temporarily allow certain manufacturers to sell blood…

6 hours ago
гранит лезники